COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,877 Articles (22,568 medRxiv, 8,309 bioRxiv)

Most recent first Previous |  Page 279: Articles 2781-2790  | Next

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Inoue, T., Yamamoto, Y., Sato, K., Nakamura, Y., Shimizu, Y., Ogawa, M., Onodera, T., Takahashi, Y., Wakita, T., Kaneko, M. K., Fukasawa, M., Kato, Y., Noguchi, K.
10.1101/2023.10.26.564289 — Posted: 2023-10-27
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Magazine, N., Zhang, T., Bungwon, A. D., McGee, M. C., Wu, Y., Veggiani, G., Huang, W.
10.1101/2023.10.26.564184 — Posted: 2023-10-27
Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals in the Indo-Pacific
Bilgin, G. M., Munira, S. L., Lokuge, K., Glass, K.
10.1101/2023.10.26.23297613 — Posted: 2023-10-27
Assessing the causal effect of air pollution on risk of SARS-CoV-2 infection
Navaratnam, A. M. D., Beale, S., Boukari, Y., Nguyen, V., Fong, W. L. E., Braithwaite, I., Byrne, T. E., Fragaszy, E., Geismar, C., Kovar, J., Patel, P., Shrotri, M., Yavlinsky, A., Hayward, A., Khreis, H., Aldridge, R. W.
10.1101/2023.10.26.23297598 — Posted: 2023-10-26
Potential impact of annual vaccination with reformulated COVID-19 vaccines: lessons from the U.S. COVID-19 Scenario Modeling Hub
Jung, S.-m., Loo, S. L., Howerton, E., Contamin, L., Smith, C. P., Carcelen, E. C., Yan, K., Bents, S. J., Espino, J., Levander, J., Reich, N. G., Lemaitre, J. C., Sato, K., McKee, C. D., Hill, A. L., Chinazzi, M., Davis, J. T., Mu, K., Vespignani, A., Rosenstrom, E. T., Rodriguez-Cartes, S. A., Ivy, J. S., Mayorga, M. E., Swann, J. L., Espana, G., Cavany, S., Moore, S. M., Perkins, A., Chen, S., Paul, R., Janies, D., Thill, J.-C., Srivastava, A., Aawar, M. A., Bi, K., Bandekar, S. R., Bouchnita, A., Fox, S. J., Meyers, L. A., Porebski, P., Venkatramanan, S., Adiga, A., Lewis, B., Klahn, B., H
10.1101/2023.10.26.23297581 — Posted: 2023-10-26
Safety and Efficacy of Disulfiram in Hospitalized Patients with Moderate COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial.
Mota, A. C., Filho, V. C. S., Hendrickson, C. M., DeVay, R. M., Donne, M., Nguyen, A. M., Junqueira, C., Marino, M., Mehra, M., Somaratne, R., ELABD, C., Kamens, B., Cousin, W.
10.1101/2023.10.25.23297554 — Posted: 2023-10-26
Peripheral Transcriptomics in Acute and Long-Term Kidney Dysfunction in SARS-CoV2 Infection
Jayaraman, P., Rajagopal, M., Paranjpe, I., Liharska, L., Suarez-Farinas, M., Thompson, R., Del Valle, D. M., Beckmann, N., Oh, W., Sakhuja, A., Chen, A., Chen, S., Kenigsberg, E., Vaid, A., Gonzalez-Kozlova, E., Kauffman, J., Gulamali, F. F., Dellepiane, S., Vasquez-Rios, G., He, J. C., Coca, S. G., Chan, L., Schadt, E., Gnjatic, S., Merad, M., Kim-Schulze, S., Tsalik, E., Langley, R., Charney, A. W., Nadkarni, G. N.
10.1101/2023.10.25.23297469 — Posted: 2023-10-26
Medical tourism's vulnerability to COVID-19 and its path to recovery: a 10-year data analysis of international patient visits
Myung, G., Lim, J.
10.1101/2023.10.26.23297607 — Posted: 2023-10-26
Comparative Organ Disease Burden and Sequelae of Influenza and SARS-CoV-2 Infection: An Observational Study Using Real-World Data
Bartha, I., Maher, M. C., Lavrenko, V., Boundy, K., Kinter, E., Yeh, W., Corti, D., Telenti, A.
10.1101/2023.10.26.23297626 — Posted: 2023-10-26
Online trend estimation and detection of trend deviations in sub-sewershed time series of SARS-CoV-2 RNA measured in wastewater.
Ensor, K. B., Schedler, J. C., Sun, T., Schneider, R., Mulenga, A., Wu, J., Stadler, L., Hopkins, L.
10.1101/2023.10.26.23297635 — Posted: 2023-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).